Quick Answer
The MOVE+ is the rare consumer red light device with genuine laser diodes rather than LEDs alone, and at around $500 it is priced like one. Its 808 nm near-infrared sits inside the only wavelength band a dose-response review has tied to real knee pain relief, and a ten minute session clears the recommended energy window several times over. The catch is what sits above the hardware: a Class 1 laser rating that is not an FDA clearance, no study registered with ClinicalTrials.gov, and a wavelength-ranking meta-analysis that put multi-wavelength devices level with sham. Buy it as a 30 day experiment on top of strength training, not instead of it.
Affiliate disclosure: This post contains affiliate links. See our affiliate disclosure for details.
Red light therapy can take the edge off knee pain, and the Kineon MOVE+ is one of the better-built ways to try it. The evidence sits a long way short of what the marketing implies, though. We own one red light panel, a four foot unit leaning against a wall, and we have never owned a MOVE+. So what follows comes from four places. Kineon's own spec sheet. The published trials on knee osteoarthritis, the wear-and-tear kind of arthritis. The FDA and clinical trial registries. And the rival brands' own spec pages.
Last reviewed: November 2026
Quick Comparison: The MOVE+ and the Alternatives
| Product | Best for | Price | Coverage | Wavelengths | Irradiance (mW/cm²) | Rating |
|---|---|---|---|---|---|---|
| Kineon MOVE+ | 808 nm laser diodes | ~$500 | 3 modules, 2 emission areas each | 660 nm LED + 808 nm laser | Not published | 3.6 |
| Kineon MOVE+ refurbished (old version) | Trying the brand for less | ~$350 | Not published for this unit | Not published for this unit | Not published | 3.2 |
| Novaa Knee Ultra | Wrapping the whole knee cheaply | ~$270 | 360° full knee, 96 LEDs | 660 nm + 850 nm | 80 at contact | 4.0 |
| Recharge Health FlexBeam | 110 mW/cm² published | ~$600 reg | 3 pods, 9 LEDs | 610–650 nm + 800–850 nm | 110 | 3.9 |
Prices last checked 16 November 2026.
Irradiance means how much light power lands on each square centimetre of skin. Recharge Health publishes 110 mW/cm² for the FlexBeam and NovaaLab publishes 80 mW/cm² at contact for the Knee Ultra. Kineon publishes 50 mW of laser output per module instead, which is a different measure and will not line up beside those two.
The FlexBeam price needs a word too. It was selling at around $480 the day we checked, against a $599 list price, as part of a sale Recharge Health was running. We have quoted the regular price above, because the sale will end and you should know what the thing normally costs.
What the MOVE+ Actually Is
Recharge Health lists 9 LEDs in the FlexBeam and NovaaLab lists 96 in the Knee Ultra. Kineon's spec sheet lists laser diodes, and that is the whole argument for its price.
Kineon publishes the breakdown per module: 8 deep-red LEDs at 660 nm, and 10 near-infrared Class 1 laser diodes at 808 nm. The laser diodes are rated at 5 mW each, giving 50 mW of laser output per module. The LED side runs at 80 mW per emission area, with two emission areas per module, so 160 mW of red LED per module. A full unit is three modules strapped around the joint.
This is where buyers get misled. The FDA's laser classification puts Class 1 in the band it calls non-hazardous, so the rating is about safety. A 510(k) clearance is a different thing entirely: the order the FDA issues when it finds a device much the same as one already on sale, and clears it to be sold.
The near-infrared number is the one that matters, and Kineon's own case for its 808 nm is depth. The MOVE+, the company says, "uses clinically studied wavelengths designed to penetrate deep into joints and soft tissue". If you want the longer version of how that works, we have written it up in our red light therapy wavelengths guide.
The Evidence, Ranked by How Much It Should Move You
This is a category where brands cite the research on light in general and leave you to assume it covers their device. Kineon's product page says the MOVE+ is "Backed by 9,600+ research papers". Below are the ones we found that measured knees.
What genuinely supports it
The strongest result in the MOVE+'s favour is a 2019 review in BMJ Open. It pooled 22 randomised trials covering 1,063 people with knee arthritis. Every trial in it was placebo-controlled, real light against a fake device. Pain fell 14.23 mm further than the fake by the end of treatment, measured on a visual analogue scale, the pain line patients mark themselves. Its 95% confidence interval, the range the true effect most likely sits in, ran from 7.31 to 21.14. Where trials used what the authors judged the right dose, the drop was 18.71 mm.
That review's conclusion is unusually specific, and it is good news for Kineon. Low-level laser therapy means the weak light this whole category sells, not anything a surgeon uses. The review concluded that it reduces knee arthritis pain and disability at one specific dose. That dose is 4 to 8 joules per spot treated, at a 785 to 860 nm wavelength. A joule is just a measure of how much light energy goes in, which is power multiplied by time. At 904 nm the figure is 1 to 3 joules. The MOVE+'s 808 nm lands inside that first band.
Kineon recommends 10 to 15 minutes a day. It publishes 50 mW of laser output per module. The review's window is 4 to 8 joules per treatment spot.
The wavelength problem
Then there is a 2024 network meta-analysis that did something more awkward. It pooled 13 studies covering 673 people, and ranked the wavelengths against one another on a cumulative ranking curve.
Light beat the fake device for pain, by 0.96 on the standardised mean difference, the yardstick researchers use for effect size, with a 95% confidence interval of 0.31 to 1.61. It did not beat the fake for function, at 0.21 on a range of minus 0.11 to 0.53, nor for stiffness, at 0.07 from minus 0.25 to 0.39. So pain relief, maybe. A knee that works better, no.
The ranking is the awkward part. The most effective wavelength for knee arthritis pain was 904 to 905 nm, scoring 86.90% in the paper's ranking. Multi-wavelength devices, which is exactly what a 660 nm plus 808 nm unit is, came out at 0.83 on a range of minus 0.06 to 1.72. In the authors' own words, multi-wavelength therapy "showed similar KOA pain reduction compared to sham LLLT", KOA meaning knee osteoarthritis and sham meaning the fake device.
The same paper rates the quality of evidence for light versus sham as low, and for the multi-wavelength comparison as very low, so this is not a finding to treat as settled either.
The trial that should give you pause
A 2023 trial in the Brazilian Journal of Physical Therapy ran for six months. It was double-blind, so neither the patients nor the staff knew who got what. Its 127 patients were split three ways: strengthening exercises alone, exercises plus real light, and exercises plus a dummy light.
There was no difference between the groups on pain, physical function or quality of life, at any follow-up. All three groups showed significant, clinically relevant improvements on all three measures. The exercise did the work.
A 2024 review in Physical Therapy lands in a similar place from the other direction. It covered 10 studies and 542 people. Light did reduce pain at rest compared with a fake device, at minus 0.7 on that same yardstick, with a 95% confidence interval of minus 1.1 to minus 0.2. The authors call that a moderate effect. Then it graded confidence in that as very low. The evidence "does not allow to recommend its isolated use", it concluded, though light "may be used to complement other widely recommended therapies". Added to proper treatment rather than instead of it is the honest frame for every device here.
What Kineon has not got
ClinicalTrials.gov returns a total count of zero registered studies with Kineon as the sponsor. For a company whose pitch rests this heavily on clinical language, that is a conspicuous gap.
The Class 1 rating in the MOVE+'s published specs is a laser hazard classification, and as above, a hazard rating is not a clearance.
That does not make the device useless. Recharge Health says as much about its own device: the FlexBeam "is currently sold as a general wellness device only". But if you have been reading "clinically studied wavelengths" as "clinically tested product", the difference is worth knowing about. Our guide to FDA-cleared red light therapy devices covers which products in this space have actually been through that process.
Power is the other argument worth knowing about. A 2026 review in Frontiers in Integrative Neuroscience says light at or below 0.5 W "has generally failed in trials for deeper tissue conditions due to limited penetration and subtherapeutic dosing". Subtherapeutic means a dose too small to produce a therapeutic effect. The same review reports that Class IV clinic lasers, running at 0.5 to 80 W and around 100 times the power, "has proven successful for many of these deeper tissue indications". Read it with the conflict of interest in view: one author was paid by a Class IV laser company and the other was its chief executive. It is still an argument worth weighing, and it is made by people who sell clinic lasers.
What You Will Actually Pay
The MOVE+ sells for around $500 on Kineon's own store, with a $699 list price shown beside it.
Treat the $699 as decoration rather than a saving. We could not find out how long that discount has been running, so we have quoted the $499 the store was actually charging on the day we looked rather than the figure above it.
There is a cheaper way in. Kineon lists a refurbished unit at around $350, but read the listing title before you click: it is titled "Move+ Refurbished Old Version", so it is an older model rather than a refurbished current one. We could not find published wavelength or output figures for it, which means you cannot check it against the specs above. Well below the current model's price, that may still be the right call for someone who wants to find out whether light helps their knee at all.
The returns terms need reading too. Kineon offers a 30 day money-back guarantee, described on the product page as "no questions asked". The terms then ask for something: daily use of 5 to 15 minutes for at least three to four weeks before a refund. That is fair enough for a treatment that needs repetition, but it is worth knowing before you count on the 30 days.
Warranty is one year. Kineon's own storefront carries 1,610 reviews, which is a brand-controlled number on a brand-controlled page, so weight it accordingly.
The Alternatives Worth Knowing About
Novaa Knee Ultra at around $270 is the one that makes the MOVE+ work hardest for its money. It wraps 360° around the knee with 96 LEDs at 660 nm and 850 nm, publishes 80 mW/cm² at contact, and runs 20 minute sessions. Its 96 emitters are LEDs rather than laser diodes, and its near-infrared 850 nm sits inside the same 785 to 860 nm band the BMJ Open review endorsed. It also carries a 60 day money-back guarantee against Kineon's 30, and a one year warranty you can extend to three. For a painful knee, that combination is hard to argue with.
Recharge Health FlexBeam → is the alternative we would look at next: three pods, worn strapped on, at around $600 regular. It publishes the highest irradiance here at 110 mW/cm². That comes from 6 near-infrared and 3 red LEDs across 3 pods, at 610 to 650 nm red and 800 to 850 nm near-infrared. Where Kineon's spec sheet lists laser diodes, Recharge Health's lists LEDs. The guarantee is 60 days against Kineon's 30. Two caveats. The newer FlexBeam 2 Connect runs around $650. And the app costs $4.99 a month after a 60 day trial, though Recharge Health says the app is optional.
A panel is the other route entirely, trading the strap-it-on convenience for a larger treated area. We compare those in the best portable red light therapy devices.
Buyer's Guide: Who This Is For
Buy the MOVE+ if you want laser output at 808 nm. The BMJ Open review's dose conclusion covers 785 to 860 nm. We would only buy it to work on one joint, used daily. The hardware is the reason to pick it.
Buy the Novaa Knee Ultra instead if the joint is your knee and the budget matters. Full wrap coverage, a published irradiance figure, 60 days to return it against Kineon's 30, and $270 against $499.
Buy the FlexBeam instead if you want one device for several body parts and you care about published power density more than laser versus LED.
Do not buy any of them if you are hoping to skip the strength work. In the 2023 trial, adding light to an exercise programme produced no extra benefit over a dummy light, and all three groups improved. Light is the optional extra here, and the rehab is the treatment. Our red light therapy for pain guide goes further into which pain conditions have the better evidence behind them.
On medical claims, none of this is advice about your knee. The reviews above found light reduced knee arthritis pain more than a fake device, and the 2024 Physical Therapy review rated confidence in that at very low while saying light "may be used to complement other widely recommended therapies". Complement is the word to hold on to.
FAQ
Does the Kineon MOVE+ actually work for knee pain?
A 2019 BMJ Open review of 22 trials found the treatment cut knee arthritis pain by 14.23 mm more than a fake device. Its dose conclusion covers 785 to 860 nm, and the MOVE+ runs at 808 nm. But a 2024 ranking study found multi-wavelength devices showed similar pain reduction to a fake device, and the 2023 trial found no benefit when light was added to strength training. ClinicalTrials.gov lists no studies at all with Kineon as sponsor.
Is the Kineon MOVE+ FDA approved?
No. The "Class 1" in its specs is a laser hazard classification, which the FDA places in the band it calls non-hazardous. A 510(k) clearance is a separate thing: the order the FDA issues on finding a device much the same as one already marketed, clearing it for sale. Recharge Health states that its FlexBeam "is currently sold as a general wellness device only".
How much does the Kineon MOVE+ cost?
Around $500 on Kineon's own store, shown against a $699 list price. Kineon also lists a refurbished unit at around $350, though that one is described as an old version rather than a refurbished current model. Prices last checked 16 November 2026.
How long do you use the MOVE+ for?
Kineon recommends 10 to 15 minutes a day, up to twice daily, and a maximum of 30 minutes on any one area. The refund terms require daily use of 5 to 15 minutes for at least three to four weeks. Read together, those terms ask for repetition rather than long single sessions.
Is the Kineon MOVE+ better than the FlexBeam?
They win on different things. Kineon's spec sheet lists 808 nm laser diodes; Recharge Health's lists LEDs. The FlexBeam publishes a higher irradiance at 110 mW/cm², covers more of the body, and gives you 60 days to return it against Kineon's 30. ClinicalTrials.gov lists no studies with Kineon as sponsor. If a knee is the whole problem, the cheaper Novaa Knee Ultra is a more direct answer than either.
Can red light therapy replace knee surgery or injections?
No. A 2024 ranking study found light superior to a fake device for pain, but not for function or stiffness. A 2024 review in Physical Therapy rated confidence in the pain findings as very low. It concluded the evidence "does not allow to recommend its isolated use", while allowing that light "may be used to complement other widely recommended therapies".
Does the MOVE+ need a subscription?
No. Kineon's published terms for the MOVE+ cover a 1 year warranty and a 30 day money-back guarantee. The comparison worth making is the FlexBeam, whose companion app costs $4.99 a month after a 60 day free trial, though Recharge Health states that app is optional rather than required.
Our Verdict
Spending our own money on a red light device for a painful knee today, we would buy the Novaa Knee Ultra at around $270. Not the MOVE+ at around $500. Full 360° coverage, a published irradiance figure, 60 days to send it back, and a near-infrared wavelength inside the band the research endorses. We rate the MOVE+ the better-built device, and real laser diodes at 808 nm are not a gimmick. On our reading of the research, though, the extra money buys build quality rather than better odds. ClinicalTrials.gov lists no studies with Kineon as sponsor. And in the 2023 trial, every group doing exercise improved whether or not it got light. Buy the light as something you add to that, on a return window you have actually read, and keep the receipt.
For more on where this fits, see our red light therapy hub, or read about us and how we rank this gear.
Our Top Pick
Kineon MOVE+
From ~$500
Before you buy
Where the premium is materials, not marketing
We take the spec sheets apart across saunas, cold plunge, red light and recovery, and show where the flagship price buys real hardware, and where it just buys the logo.
Disclosure: This article contains affiliate links. If you purchase through these links, Bankroll Zen may earn a commission at no extra cost to you. We only recommend products we genuinely believe in. Learn more in our affiliate disclosure.